SCHEMBL6182083

SCHEMBL6182083

CCN(CC)CCN1C(=O)C(O)(c2ccccc2Cl)c2c(Br)cc(C#CCN(CC)C(N)=O)cc21

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 16/20 0.56
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179340 0.89 GHSR (0.70) GHSR
SCHEMBL6182085 0.85 GHSR (0.52) GHSRMEN1KMT2ATP53MAPT
SCHEMBL6176647 0.84 GHSR (0.57) GHSRMEN1KMT2ATP53MAPT
SCHEMBL6180161 0.82 GHSR (0.77) GHSRMEN1KMT2ATP53MAPT
SCHEMBL6178327 0.81 GHSR (0.48) GHSR
SCHEMBL6179750 0.81 GHSR (0.48) GHSR
SCHEMBL6178328 0.81 GHSR (0.48) GHSR
SCHEMBL6181657 0.79 GHSR (0.59) GHSRMEN1KMT2ATP53MAPT
SCHEMBL2576235 0.76 GHSR (0.69) GHSR
SCHEMBL6178340 0.76 GHSR (0.59) GHSRTP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105376-B1 OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS SUMITOMO PHARMA (JP) 2005-02-09 EP disclosed
US-6576656-B1 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2003-06-10 US disclosed
EP-1105376-A1 OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-06-13 EP disclosed
WO-2000010975-A1 OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2000-03-02 WO disclosed